Aperçu des produits pour anti-BCL2L1 (BCL2L1) Anticorps

Full name:
anti-BCL2-Like 1 Anticorps (BCL2L1)
Chez www.anticorps-enligne.fr sont 516 BCL2-Like 1 (BCL2L1) Anticorps de 37 de différents fournisseurs disponibles. De plus, nous expédions BCL2L1 Kits (22) et BCL2L1 Protéines (17) et beaucoup plus de produits pour cette protéine. Un total de 579 BCL2L1 produits sont actuellement listés.
Bcl(X)L, bcl-X, bcl-x(l), bcl-xl, BCL-XL/S, Bcl-Xs, Bcl2l, BCL2L1, Bclx, BCLXL, BCLXS, PPP1R52, xR11
afficher tous les anticorps Gène GeneID UniProt
BCL2L1 60480  
BCL2L1 598 Q07817
BCL2L1 24888 P53563

Afficher toutes les espèces

Afficher tous les synonymes

Réactivités les plus populaires pour anti-BCL2L1 (BCL2L1) Anticorps

Sélectionnez vos espèces et l'application

anti-Mouse (Murine) BCL2L1 Anticorps:

anti-Human BCL2L1 Anticorps:

anti-Rat (Rattus) BCL2L1 Anticorps:

Tous anti-BCL2L1 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-BCL2L1 Anticorps mieux référencés

  1. Human Polyclonal BCL2L1 Primary Antibody pour ELISA, IF (p) - ABIN675129 : Wang, Ma, Su: NF-?B pathway contributes to cadmium-induced apoptosis of porcine granulosa cells. dans Biological trace element research 2013 (PubMed)
    Show all 5 references for 675129

  2. Human Monoclonal BCL2L1 Primary Antibody pour FACS, IF - ABIN180627 : Hsu, Youle: Nonionic detergents induce dimerization among members of the Bcl-2 family. dans The Journal of biological chemistry 1997 (PubMed)
    Show all 3 references for 180627

  3. Human Polyclonal BCL2L1 Primary Antibody pour IHC, ELISA - ABIN1531788 : Cheng, Levine, Boise, Thompson, Hardwick: Bax-independent inhibition of apoptosis by Bcl-XL. dans Nature 1996 (PubMed)
    Show all 3 references for 1531788

  4. Human Polyclonal BCL2L1 Primary Antibody pour IP, WB - ABIN223050 : Cordiali-Fei, Ardigo, Mastroianni, Giuliani, D Agosto, Bordignon, Trento, Vento, Berardesca: Serum cytokines and biohumoral immunological characterization of psoriatic patients in long term etanercept treatment. dans International journal of immunopathology and pharmacology 2008 (PubMed)
    Show all 3 references for 223050

  5. Human Polyclonal BCL2L1 Primary Antibody pour IHC, ELISA - ABIN1532818 : Sattler, Liang, Nettesheim, Meadows, Harlan, Eberstadt, Yoon, Shuker, Chang, Minn, Thompson, Fesik: Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. dans Science (New York, N.Y.) 1997 (PubMed)
    Show all 3 references for 1532818

  6. Human Polyclonal BCL2L1 Primary Antibody pour IHC, ELISA - ABIN1533140 : Boise, González-García, Postema, Ding, Lindsten, Turka, Mao, Nuñez, Thompson: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. dans Cell 1993 (PubMed)
    Show all 2 references for 1533140

  7. Human Polyclonal BCL2L1 Primary Antibody pour IHC, ELISA - ABIN1532107 : Deloukas, Matthews, Ashurst, Burton, Gilbert, Jones, Stavrides, Almeida, Babbage, Bagguley, Bailey, Barlow, Bates, Beard, Beare, Beasley, Bird, Blakey, Bridgeman, Brown, Buck, Burrill, Butler, Carder et al.: The DNA sequence and comparative analysis of human chromosome 20. ... dans Nature 2002 (PubMed)
    Show all 2 references for 1532107

  8. Cow (Bovine) Polyclonal BCL2L1 Primary Antibody pour WB - ABIN2774598 : Bachelor, Bowden: Ultraviolet A-induced modulation of Bcl-XL by p38 MAPK in human keratinocytes: post-transcriptional regulation through the 3'-untranslated region. dans The Journal of biological chemistry 2004 (PubMed)

  9. Cow (Bovine) Polyclonal BCL2L1 Primary Antibody pour WB - ABIN2792119 : Xu, Xu, Palmer, Reed: BI-1 regulates endoplasmic reticulum Ca2+ homeostasis downstream of Bcl-2 family proteins. dans The Journal of biological chemistry 2008 (PubMed)

  10. Cow (Bovine) Polyclonal BCL2L1 Primary Antibody pour WB - ABIN2779336 : ONeill, Manion, Maguire, Hockenbery: BCL-XL dimerization by three-dimensional domain swapping. dans Journal of molecular biology 2006 (PubMed)

Plus d’anticorps contre BCL2L1 partenaires d’interaction

Mouse (Murine) BCL2-Like 1 (BCL2L1) interaction partners

  1. Bcl-xL deficiency induced apoptosis in a select population of differentiated neurons and led to severe neurobehavioral abnormalities.

  2. loss of PUMA (Montrer BBC3 Anticorps) had no impact on the loss of platelets caused by loss of BCL-XL. It therefore remains to be established whether other BH3-only (Montrer BBC3 Anticorps) proteins play a critical role in induction of apoptosis in platelets or whether their death is controlled solely by the interactions between BCL-XL with BAK (Montrer BAK1 Anticorps) and BAX (Montrer BAX Anticorps).

  3. MLF1 (Montrer MLF1 Anticorps) is negatively regulated by 14-3-3 (Montrer YWHAQ Anticorps) via binding to, and blocking, MLF1 (Montrer MLF1 Anticorps)'s Bcl-2 (Montrer BCL2 Anticorps) homology domain 3 and thereby preventing Bcl-XL from associating with MLF1 (Montrer MLF1 Anticorps).

  4. Genetic and pharmacological inhibition of BCL-W (Montrer BCL2L2 Anticorps) and BCL-XL causes directed elimination of senescent cells.

  5. Valproic acid sensitized TRAIL-resistant papillary thyroid carcinoma cells to apoptotic cell death through involvement of Nrf2 (Montrer NFE2L2 Anticorps) and Bcl-xL.

  6. The influence of chronic ethanol consumption on the expression of the Bdnf (Montrer BDNF Anticorps), Bax (Montrer BAX Anticorps), Bcl-xL, and CASP3 (Montrer CASP3 Anticorps) genes was studied in the brain structures of B6-1473C (C/C) and B6-1473G (G/G) mice that had been obtained on the base of the C57BL/6 strain.

  7. despite its role in Bax (Montrer BAX Anticorps) inhibition, Bcl-xL also primes mitochondria to permeabilization and cytochrome c (Montrer CYCS Anticorps) release.

  8. These findings indicate that eosinophil survival is largely regulated by betac chain-induced NF-kappaB (Montrer NFKB1 Anticorps) activation and subsequent induction of Bcl-x

  9. these data indicate that beta-cell apoptosis is, in part, attributable to the modulation of 5'SS selection in the Bcl-x pre-mRNA by bioactive lipids modulated by iPLA2beta (Montrer PLA2G6 Anticorps).

  10. only loss of both Bclx alleles markedly forestalled tumorigenesis, loss of a single Bim (Montrer BCL2L11 Anticorps) allele overcame this blockade.

Human BCL2-Like 1 (BCL2L1) interaction partners

  1. BC200 knockout suppresses tumor cell growth in vitro and in vivo by expression of the pro-apoptotic Bcl-xS isoform.

  2. Bcl-xL inhibits GAS-induced autophagy directly by suppressing autophagosome-lysosome fusion and indirectly by suppressing GAS internalization via interaction with Beclin 1 (Montrer BECN1 Anticorps)-UVRAG (Montrer UVRAG Anticorps).

  3. The combination of 2-deoxyglucose (2-DG) and ABT-199 initiated cell death through the reduction of myeloid cell leukemia sequence 1 protein (Mcl-1 (Montrer MCL1 Anticorps)) expression and c-Jun N-terminal kinase 1 (JNK1 (Montrer MAPK8 Anticorps)) activation and subsequent Bcl-xL protein degradation.

  4. Bcl-xL is an exosomal caspase-3 (Montrer CASP3 Anticorps) substrate and that this processing is required for the uptake of exosomes by recipient cells.

  5. dynamic Bcl-xL(S49) and (S62) phosphorylation/dephosphorylation cycles are important in the maintenance of chromosome integrity during mitosis in normal cells

  6. in addition to MCL-1 (Montrer MCL1 Anticorps), BCL-XL is heterogeneously expressed in HMCLs and patient samples. The expression profile of BCL-XL relative to BCL-2 (Montrer BCL2 Anticorps) and MCL-1 (Montrer MCL1 Anticorps) may be an important predictor of response to venetoclax sensitivity as a monotherapy and in combination with bortezomib.

  7. Mono treatment with lexatumumab was not sufficient to induce apoptosis in pancreatic cancer cells, whereas focal adhesion kinase inhibitor PF573228 significantly sensitized lexatumumab-induced apoptosis. Western blotting analysis revealed that lexatumumab and PF573228 combination treatment increased death receptor 5 (Montrer TNFRSF10B Anticorps) but decreased Bcl-xL expression.

  8. Reduced lifetimes of the donor were partially restored by coexpression of HIF-1alpha (Montrer HIF1A Anticorps) or Bcl-xL, binding proteins of IPAS (Montrer HIF3A Anticorps) in the nucleus and mitochondria, respectively.

  9. mechanistic studies, inhibition of SRC (Montrer SRC Anticorps) and PKCdelta (Montrer PKCd Anticorps) completely ablated the ability of MDA-7/IL-24 (Montrer IL24 Anticorps) to reduce the Bcl-x(L)/(s) mRNA ratio and cell viability. These findings show that Bcl-x(s) expression is an important mediator of MDA-7/IL-24 (Montrer IL24 Anticorps)-induced cytotoxicity requiring the SRC (Montrer SRC Anticorps)/PKCdelta (Montrer PKCd Anticorps) signaling axis in NSCLC cells.

  10. Resistance induced in newly formed cancer stem cells is mediated by the anti-apoptotic molecule BCL-XL and inhibition of BCL-XL with the BH3 mimetic ABT-737 sensitizes these cancer cells toward chemotherapy.

Pig (Porcine) BCL2-Like 1 (BCL2L1) interaction partners

  1. interleukin-6 (Montrer IL6 Anticorps), endothelin ET-1 (Montrer EDN1 Anticorps), and apoptotic Bak (Montrer BAK1 Anticorps) and Bcl-XL genes have roles in small bowel transplantation, in a swine model of ischemia and reperfusion injury

  2. Bcl-xL was significantly decreased in haploid parthenotes compared with the diploid parthenotes. These results suggest that the haploid state affects apoptosis-related gene expression which results in increased apoptosis

  3. CONCLUSION(S): (1) Apoptosis is involved in follicular atresia; (2) Bcl-2 (Montrer BCL2 Anticorps) is induced by warm ischemia; and (3) cryopreservation insult does not alter the apoptotic signals with short tissue preparation time.

  4. Bcl-Xl deamidation and methylation has a role in protein isoaspartate methyltransferase prevention of apoptosis induced by oxidative stress in endothelial cells

  5. Data show that cysteine significantly reduced the expression of pro-inflammatory cytokines, including TNF-alpha (Montrer TNF Anticorps), IL-6 (Montrer IL6 Anticorps), IL-12p40, IL-1beta (Montrer IL1B Anticorps), and resulted in increased expression of the apoptosis initiator caspase-8 (Montrer CASP8 Anticorps) and bcl2L1.

Cow (Bovine) BCL2-Like 1 (BCL2L1) interaction partners

  1. amplification and characterization of partial regions of exons 2 and 3 of the bovine BCL2L1 gene

  2. Data show that Bcl-x(L) expression is increased in the pulmonary artery undergoing chronic pulmonary vascular remodeling.

Rabbit BCL2-Like 1 (BCL2L1) interaction partners

  1. This study leads to conclude that BCLXL peak expression at the zygotic genome activation phase may be a requirement for embryo development

  2. In this study evidence is provided that exogenous PGF2alpha differentially modulates luteal expression of BCL2L1 transcripts and protein depending on luteal stage.

Xenopus laevis BCL2-Like 1 (BCL2L1) interaction partners

  1. repression of radiation-induced apoptosis by overexpression of Bcl-xL during embryonic development depends upon the timing of its expression and post-translational events that enable the protein to become effective

BCL2L1 profil antigène

Antigen Summary

The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The proteins encoded by this gene are located at the outer mitochondrial membrane, and have been shown to regulate outer mitochondrial membrane channel (VDAC) opening. VDAC regulates mitochondrial membrane potential, and thus controls the production of reactive oxygen species and release of cytochrome C by mitochondria, both of which are the potent inducers of cell apoptosis. Two alternatively spliced transcript variants, which encode distinct isoforms, have been reported. The longer isoform acts as an apoptotic inhibitor and the shorter form acts as an apoptotic activator.

Alternative names and synonyms associated with BCL2L1

  • BCL2-like 1 (bcl2l1) anticorps
  • BCL2-like 1 (BCL2L1) anticorps
  • BCL2-like 1 (LOC100224900) anticorps
  • transgene insertion 2, Craig B Thompson (Tg(BCL2L1)2Cbt) anticorps
  • BCL2-like 1 (Bcl2l1) anticorps
  • Bcl2-like 1 (Bcl2l1) anticorps
  • Bcl(X)L anticorps
  • bcl-X anticorps
  • bcl-x(l) anticorps
  • bcl-xl anticorps
  • BCL-XL/S anticorps
  • Bcl-Xs anticorps
  • Bcl2l anticorps
  • BCL2L1 anticorps
  • Bclx anticorps
  • BCLXL anticorps
  • BCLXS anticorps
  • PPP1R52 anticorps
  • xR11 anticorps

Protein level used designations for anti-BCL2-Like 1 (BCL2L1) Anticorps

BCL2-like 1 , apoptosis regulator Bcl-X , bcl-2-like protein 1 , protein phosphatase 1, regulatory subunit 52 , B-cell leukemia/lymphoma x , anti-apoptosis regulatory protein , bcl2-L-1 , B cell lymphoma 2 like , B cell lymphoma like X , anti-apoptotic Bcl-xL , BCL2-like protein 1 , Bcl-X , BCLX protein , apoptosis regulator R11

447991 Xenopus (Silurana) tropicalis
458156 Pan troglodytes
100224900 Taeniopygia guttata
60480 Mus musculus
598 Homo sapiens
12048 Mus musculus
24888 Rattus norvegicus
397536 Sus scrofa
403618 Canis lupus familiaris
282152 Bos taurus
100008875 Oryctolagus cuniculus
493701 Felis catus
443061 Ovis aries
373954 Gallus gallus
398251 Xenopus laevis
Fournisseurs de qualité sélectionnés pour anti-BCL2L1 (BCL2L1) Anticorps
Avez-vous cherché autre chose?